跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bricanyl - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bricanyl
Approved
STANDARD
Bricanyl
AstraZeneca AB
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
90cb93ef9744c7cc
Company
AstraZeneca AB
Type
Standard
Approval Details
Approval Id
90cb93ef9744c7cc
Drug Approval Philippines Name
Bricanyl
Product Name
Bricanyl
Registration Number
DR-XY1680
Brand Name
Bricanyl
Generic Name
Terbutaline Sulfate
Dosage Form
Solution for Nebulizing
Dosage Strength
2.5 mg/mL (5 mg/2 mL)
Manufacturer
AstraZeneca AB
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Company Detail Path
/organization/astrazeneca-ab
Issuance Date
28 April 2021
Expiry Date
23 April 2026
Pharmacologic Category
Polyethylene (PE) Plastic Ampoule in 2 mL (net content) x 5's wrapped in white aluminium pouch (Box of 20's)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
90cb93ef9744c7cc
Type
Standard
Back to Philippines FDA Approvals